Back

State of the Art: TAVI indications and adoption: a dynamic field

28 August 2017 (14:01 - 14:18)
Organised by:
Congress Presentation Part of: TAVI: a new standard for aortic valve replacement? Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Bernard David Prendergast

St Thomas', London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.
Professor E. Durand (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)
Doctor U. Fischer-Rasokat (Bad Nauheim, DE)
Abstract
Presentation thumbnail
Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis
Doctor B. Alushi (Munich, DE)
Abstract Slides Video
Presentation thumbnail
TAVI complications: incidence, trends and management.
Professor A. Chieffo (Milan, IT)
Slides Video

Access the full session

Session thumbnail
TAVI: a new standard for aortic valve replacement?

The Event

Event poster

ESC Congress 2017

28 August 2017 14:01 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources